Literature DB >> 24993046

Cardiac-restricted overexpression or deletion of tissue inhibitor of matrix metalloproteinase-4: differential effects on left ventricular structure and function following pressure overload-induced hypertrophy.

William M Yarbrough1, Catalin Baicu2, Rupak Mukherjee2, An Van Laer2, William T Rivers2, Richard A McKinney2, Corey B Prescott2, Robert E Stroud2, Parker D Freels3, Kia N Zellars3, Michael R Zile2, Francis G Spinale4.   

Abstract

Historically, the tissue inhibitors of matrix metalloproteinases (TIMPs) were considered monochromatic in function. However, differential TIMP profiles more recently observed with left ventricular (LV) dysfunction and matrix remodeling suggest more diverse biological roles for individual TIMPs. This study tested the hypothesis that cardiac-specific overexpression (TIMP-4OE) or deletion (knockout; TIMP-4KO) would differentially affect LV function and structure following pressure overload (LVPO). LVPO (transverse aortic constriction) was induced in mice (3.5 ± 0.1 mo of age, equal sex distribution) with TIMP-4OE (n = 38), TIMP-4KO (n = 24), as well as age/strain-matched wild type (WT, n = 25), whereby indexes of LV remodeling and function such as LV mass and ejection fraction (LVEF) were determined at 28 days following LVPO. Following LVPO, both early (7 days) and late (28 days) survival was ~25% lower in the TIMP-4KO group (P < 0.05). While LVPO increased LV mass in all groups, the relative hypertrophic response was attenuated with TIMP-4OE. With LVPO, LVEF was similar between WT and TIMP-4KO (48 ± 2% and 45 ± 3%, respectively) but was higher with TIMP-4OE (57 ± 2%, P < 0.05). With LVPO, LV myocardial collagen expression (type I, III) increased by threefold in all groups (P < 0.05), but surprisingly this response was most robust in the TIMP-4KO group. These unique findings suggest that increased myocardial TIMP-4 in the context of a LVPO stimulus may actually provide protective effects with respect to survival, LV function, and extracellular matrix (ECM) remodeling. These findings challenge the canonical belief that increased levels of specific myocardial TIMPs, such as TIMP-4 in and of themselves, contribute to adverse ECM accumulation following a pathological stimulus, such as LVPO.

Entities:  

Keywords:  pressure-overload hypertrophy; remodeling; tissue inhibitors of metalloproteinase

Mesh:

Substances:

Year:  2014        PMID: 24993046      PMCID: PMC4187400          DOI: 10.1152/ajpheart.00063.2014

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  37 in total

1.  Regression of left ventricular hypertrophy after surgical therapy for aortic stenosis is associated with changes in extracellular matrix gene expression.

Authors:  T Walther; A Schubert; V Falk; C Binner; A Kanev; S Bleiziffer; C Walther; N Doll; R Autschbach; F W Mohr
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

2.  Effects of gene deletion of the tissue inhibitor of the matrix metalloproteinase-type 1 (TIMP-1) on left ventricular geometry and function in mice.

Authors:  L Roten; S Nemoto; J Simsic; M L Coker; V Rao; S Baicu; G Defreyte; P J Soloway; M R Zile; F G Spinale
Journal:  J Mol Cell Cardiol       Date:  2000-01       Impact factor: 5.000

Review 3.  Matrix metalloproteinases: regulation and dysregulation in the failing heart.

Authors:  Francis G Spinale
Journal:  Circ Res       Date:  2002-03-22       Impact factor: 17.367

4.  Time course of regression of left ventricular hypertrophy after aortic valve replacement.

Authors:  E S Monrad; O M Hess; T Murakami; H Nonogi; W J Corin; H P Krayenbuehl
Journal:  Circulation       Date:  1988-06       Impact factor: 29.690

5.  Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients.

Authors:  Javier Díez; Ramón Querejeta; Begoña López; Arantxa González; Mariano Larman; José L Martínez Ubago
Journal:  Circulation       Date:  2002-05-28       Impact factor: 29.690

6.  Tissue inhibitor of metalloproteinases-4 suppresses vascular smooth muscle cell migration and induces cell apoptosis.

Authors:  Yan-Hong Guo; Wei Gao; Qian Li; Peng-Fei Li; Peng-Ying Yao; Kuanghueih Chen
Journal:  Life Sci       Date:  2004-10-01       Impact factor: 5.037

7.  Role of microtubules versus myosin heavy chain isoforms in contractile dysfunction of hypertrophied murine cardiocytes.

Authors:  Yuji Ishibashi; Masaru Takahashi; Yukihisa Isomatsu; Fei Qiao; Yoshihiro Iijima; Hirokazu Shiraishi; Janet M Simsic; Catalin F Baicu; Jeffrey Robbins; Michael R Zile; George Cooper
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-05-15       Impact factor: 4.733

8.  Myocardial infarct expansion and matrix metalloproteinase inhibition.

Authors:  Rupak Mukherjee; Theresa A Brinsa; Kathryn B Dowdy; Amelia A Scott; Julia M Baskin; Anne M Deschamps; Abigail S Lowry; G Patricia Escobar; David G Lucas; William M Yarbrough; Michael R Zile; Francis G Spinale
Journal:  Circulation       Date:  2003-02-04       Impact factor: 29.690

9.  Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement.

Authors:  H P Krayenbuehl; O M Hess; E S Monrad; J Schneider; G Mall; M Turina
Journal:  Circulation       Date:  1989-04       Impact factor: 29.690

Review 10.  Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodeling.

Authors:  Yonggang Ma; Lisandra E de Castro Brás; Hiroe Toba; Rugmani Padmanabhan Iyer; Michael E Hall; Michael D Winniford; Richard A Lange; Suresh C Tyagi; Merry L Lindsey
Journal:  Pflugers Arch       Date:  2014-02-13       Impact factor: 3.657

View more
  2 in total

1.  Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction Study.

Authors:  Michael R Zile; Pardeep S Jhund; Catalin F Baicu; Brian L Claggett; Burkert Pieske; Adriaan A Voors; Margaret F Prescott; Victor Shi; Martin Lefkowitz; John J V McMurray; Scott D Solomon
Journal:  Circ Heart Fail       Date:  2016-01       Impact factor: 8.790

2.  Estrogen receptor-α prevents right ventricular diastolic dysfunction and fibrosis in female rats.

Authors:  Tik-Chee Cheng; Jennifer L Philip; Diana M Tabima; Santosh Kumari; Bakhtiyor Yakubov; Andrea L Frump; Timothy A Hacker; Alessandro Bellofiore; Rongbo Li; Xin Sun; Kara N Goss; Tim Lahm; Naomi C Chesler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-10-16       Impact factor: 4.733

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.